- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PRÆCISIONSMEDICIN I ACHALASIA - Et multicentret, randomiseret, ikke-underlegenhedsklinisk forsøg med kort skræddersyet POEM versus standard POEM for ikke-spastisk achalasia og et multicentret, prospektivt kohortestudie af lang skræddersyet POEM for spastiske øsofagusmotilitetslidelser
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
- Navn: Elizabeth Yan, BS
- Telefonnummer: 312-908-1723
- E-mail: premedia.dcc@northwestern.edu
Undersøgelse Kontakt Backup
- Navn: Yasmin Pina, BS
- Telefonnummer: 312-503-6459
- E-mail: premedia.dcc@northwestern.edu
Studiesteder
-
-
Arizona
-
Scottsdale, Arizona, Forenede Stater, 85259
- Ikke rekrutterer endnu
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Forenede Stater, 92037
- Rekruttering
- University of California San Diego
-
Ledende efterforsker:
- Rena Yadlapati, MD
-
Kontakt:
- Alexander Gonsalves, Lead Study Coordinator
- Telefonnummer: 858-246-5236
- E-mail: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80217
- Ikke rekrutterer endnu
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Forenede Stater, 32611
- Rekruttering
- University of Florida
-
Ledende efterforsker:
- Peter Draganov, MD
-
Kontakt:
- April Goddard, Lead Study Coordinator, PA-C
- Telefonnummer: 352-273-9483
- E-mail: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Forenede Stater, 32803
- Ikke rekrutterer endnu
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Rekruttering
- Emory University
-
Ledende efterforsker:
- Anand Jain, MD
-
Kontakt:
- Halley Fowler, Lead Study Coordinator
- Telefonnummer: 404-778-3184
- E-mail: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Northwestern University
-
Ledende efterforsker:
- John Pandolfino, MD
-
Kontakt:
- Eric Pfannkuche, Lead Study Coordinator
- Telefonnummer: 312-926-4525
- E-mail: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21218
- Ikke rekrutterer endnu
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Kontakt:
- Madison Paylor, Lead Study Coordinator
- Telefonnummer: 617-726-0196
- E-mail: premedia@mgb.org
-
Ledende efterforsker:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63110
- Rekruttering
- Washington University
-
Kontakt:
- Darren Nix, Lead Study Coordinator
- Telefonnummer: 314-273-1432
- E-mail: Premediasurgerytrial@wustl.edu
-
Ledende efterforsker:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Ikke rekrutterer endnu
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28204
- Rekruttering
- Atrium Health/Wake Forest
-
Ledende efterforsker:
- Badih Elmunzer, MD
-
Kontakt:
- Greg Scarola, Lead Study Coordinator
- Telefonnummer: (704) 355-2000
- E-mail: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44109
- Rekruttering
- MetroHealth Medical Center
-
Ledende efterforsker:
- Ronnie Fass, MD
-
Kontakt:
- Stephanie Baker, Lead Study Coordinator
- Telefonnummer: 216-778-5736
- E-mail: premedia@metrohealth.org
-
Cleveland, Ohio, Forenede Stater, 44106
- Ikke rekrutterer endnu
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Ledende efterforsker:
- Dhyanesh Patel, MD
-
Kontakt:
- Larry Raber, Lead Study Coordinator
- Telefonnummer: 615-322-4643
- E-mail: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75246
- Rekruttering
- Baylor Scott & White Health
-
Kontakt:
- Neomy Flores, Lead Study Coordinator
- Telefonnummer: 214-820-9704
- E-mail: premedia@bswhealth.org
-
Ledende efterforsker:
- Vani Albertson Konda, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Standard Myotomi
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Eksperimentel: Tilpasset kort myotomi
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical Response-Overall
Tidsramme: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Tidsramme: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Tidsramme: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Tidsramme: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PREMEDIA (Pro00083748) - 01
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- CSR
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .